Jordan R. Smith

1.0k total citations
27 papers, 781 citations indexed

About

Jordan R. Smith is a scholar working on Infectious Diseases, Clinical Biochemistry and Pharmacology. According to data from OpenAlex, Jordan R. Smith has authored 27 papers receiving a total of 781 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Infectious Diseases, 13 papers in Clinical Biochemistry and 12 papers in Pharmacology. Recurrent topics in Jordan R. Smith's work include Antimicrobial Resistance in Staphylococcus (22 papers), Bacterial Identification and Susceptibility Testing (13 papers) and Antibiotics Pharmacokinetics and Efficacy (12 papers). Jordan R. Smith is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (22 papers), Bacterial Identification and Susceptibility Testing (13 papers) and Antibiotics Pharmacokinetics and Efficacy (12 papers). Jordan R. Smith collaborates with scholars based in United States, Canada and Colombia. Jordan R. Smith's co-authors include Michael J. Rybak, Katie E. Barber, Juwon Yim, Kimberly C. Claeys, Jeffrey M. Rybak, George Sakoulas, Cynthia B. Snider, Warren E. Rose, Michelle Turner and Razieh Kebriaei and has published in prestigious journals such as SHILAP Revista de lepidopterología, Antimicrobial Agents and Chemotherapy and Journal of Antimicrobial Chemotherapy.

In The Last Decade

Jordan R. Smith

26 papers receiving 760 citations

Peers

Jordan R. Smith

EPIDE

PHARM

Luis Eduardo López-Cortés Spain

Molly E. Steed United States

Kevin W. Ward United States

Ronda L. Akins United States

Kim Credito United States

Steven Leonard United States

Matthew G. Stilwell United States

Anthony M. Casapao United States

Jeffrey R. Aeschlimann United States

A. Evans United States

Luis Eduardo López-Cortés Spain

Jordan R. Smith

419 ×0.8

214 ×0.8

278 ×1.3

EPIDE

222 ×1.0

PHARM

96 ×0.5

Citations per year, relative to Jordan R. Smith Jordan R. Smith (= 1×) peers Luis Eduardo López-Cortés

Countries citing papers authored by Jordan R. Smith

Since Specialization

Citations

This map shows the geographic impact of Jordan R. Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jordan R. Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jordan R. Smith more than expected).

Fields of papers citing papers by Jordan R. Smith

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jordan R. Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jordan R. Smith. The network helps show where Jordan R. Smith may publish in the future.

Co-authorship network of co-authors of Jordan R. Smith

This figure shows the co-authorship network connecting the top 25 collaborators of Jordan R. Smith. A scholar is included among the top collaborators of Jordan R. Smith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jordan R. Smith. Jordan R. Smith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ferguson, Michael A., et al.. (2025). Quantifying Antimicrobial Disposals at Six Community Pharmacies With Longitudinal Medication Disposal Programs: An Underappreciated Component of a One Health Approach to Antimicrobial Stewardship. Open Forum Infectious Diseases. 12(10). ofaf040–ofaf040. 1 indexed citations

Smith, Jordan R., et al.. (2023). Optimizing transitions of care antimicrobial prescribing at a community teaching hospital. SHILAP Revista de lepidopterología. 3(1). e228–e228.

Smith, Jordan R., et al.. (2021). The Use of Long-Acting Lipoglycopeptides for the Treatment of Serious, Off-label Infections: a Review of the Literature. Current Infectious Disease Reports. 23(12). 1 indexed citations

Smith, Jordan R., Jeffrey M. Rybak, & Kimberly C. Claeys. (2020). Imipenem‐Cilastatin‐Relebactam: A Novel β‐Lactam–β‐Lactamase Inhibitor Combination for the Treatment of Multidrug‐Resistant Gram‐Negative Infections. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 40(4). 343–356. 60 indexed citations

Jorgensen, Sarah C J, Kyle P. Murray, Abdalhamid M Lagnf, et al.. (2020). A Multicenter Evaluation of Vancomycin-Associated Acute Kidney Injury in Hospitalized Patients with Acute Bacterial Skin and Skin Structure Infections. Infectious Diseases and Therapy. 9(1). 89–106. 29 indexed citations

Trinh, Trang D, Jordan R. Smith, & Michael J. Rybak. (2019). Parenteral Fosfomycin for the Treatment of Multidrug Resistant Bacterial Infections: The Rise of the Epoxide. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 39(11). 1077–1094. 15 indexed citations

Smith, Jordan R., et al.. (2018). Evaluation of dalbavancin alone and in combination with β-lactam antibiotics against resistant phenotypes of Staphylococcus aureus. Journal of Antimicrobial Chemotherapy. 74(1). 82–86. 18 indexed citations

Turner, Michelle, et al.. (2017). Real-World Experience with Oritavancin Therapy in Invasive Gram-Positive Infections. Infectious Diseases and Therapy. 6(2). 277–289. 49 indexed citations

Smith, Jordan R., et al.. (2017). Impact of a pharmacist-driven care package on Staphylococcus aureus bacteremia management in a large community healthcare network: A propensity score-matched, quasi-experimental study. Diagnostic Microbiology and Infectious Disease. 90(1). 50–54. 23 indexed citations

10.

Rolston, Kenneth V. I., et al.. (2016). Time-kill determination of the bactericidal activity of telavancin and vancomycin against clinical methicillin-resistant Staphylococcus aureus isolates from cancer patients. Diagnostic Microbiology and Infectious Disease. 87(4). 338–342. 8 indexed citations

11.

Yim, Juwon, et al.. (2016). Evaluation of Pharmacodynamic Interactions Between Telavancin and Aztreonam or Piperacillin/Tazobactam Against Pseudomonas aeruginosa, Escherichia coli and Methicillin-Resistant Staphylococcus aureus. Infectious Diseases and Therapy. 5(3). 367–377. 5 indexed citations

12.

Yim, Juwon, et al.. (2016). β-Lactamase Inhibitors Enhance the Synergy between β-Lactam Antibiotics and Daptomycin against Methicillin-Resistant Staphylococcus aureus. Antimicrobial Agents and Chemotherapy. 61(1). 10 indexed citations

13.

Smith, Jordan R., et al.. (2016). Daptomycin in Combination with Ceftolozane-Tazobactam or Cefazolin against Daptomycin-Susceptible and -Nonsusceptible Staphylococcus aureus in an In Vitro , Hollow-Fiber Model. Antimicrobial Agents and Chemotherapy. 60(7). 3970–3975. 16 indexed citations

14.

Smith, Jordan R., et al.. (2016). Oritavancin Combinations with β-Lactams against Multidrug-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococci. Antimicrobial Agents and Chemotherapy. 60(4). 2352–2358. 23 indexed citations

15.

Smith, Jordan R., et al.. (2015). β-Lactam combinations with daptomycin provide synergy against vancomycin-resistant Enterococcus faecalis and Enterococcus faecium. Journal of Antimicrobial Chemotherapy. 70(6). 1738–1743. 100 indexed citations

16.

Barber, Katie E., et al.. (2015). Evaluation of tedizolid againstStaphylococcus aureusand enterococci with reduced susceptibility to vancomycin, daptomycin or linezolid. Journal of Antimicrobial Chemotherapy. 71(1). 152–155. 63 indexed citations

17.

Smith, Jordan R., et al.. (2015). Dalbavancin: A Novel Lipoglycopeptide Antibiotic with Extended Activity Against Gram-Positive Infections. Infectious Diseases and Therapy. 4(3). 245–258. 80 indexed citations

18.

Claeys, Kimberly C., Jordan R. Smith, Anthony M. Casapao, et al.. (2015). Impact of the Combination of Daptomycin and Trimethoprim-Sulfamethoxazole on Clinical Outcomes in Methicillin-Resistant Staphylococcus aureus Infections. Antimicrobial Agents and Chemotherapy. 59(4). 1969–1976. 25 indexed citations

19.

Smith, Jordan R., et al.. (2015). β-Lactams Enhance Daptomycin Activity against Vancomycin-Resistant Enterococcus faecalis and Enterococcus faecium in In Vitro Pharmacokinetic/Pharmacodynamic Models. Antimicrobial Agents and Chemotherapy. 59(5). 2842–2848. 44 indexed citations

20.

Smith, Jordan R., Kimberly C. Claeys, Katie E. Barber, & Michael J. Rybak. (2014). High-Dose Daptomycin Therapy for Staphylococcal Endocarditis and When to Apply It. Current Infectious Disease Reports. 16(10). 429–429. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact